BerGenBio
Boss of tiny Oxford firm is 'extremely optimistic' over one-a-day pill it has developed to combat coronavirus
- BerGenBio, a British-Norwegian company has just 38 staff working for them
- The firm believe they have found the key to combat the coronavirus
- Chief executive of the company said tests on SARS-Cov-2 'showed big effects'
- It works by stopping the virus from utilising a naturally occurring protein, AXL
- The small firm is competing with pharmaceutical giants to find a treatment
Already have an account?
Login here
